Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
Myles David C. has filed 2 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 14, 2026.
On the most recent filing, Myles David C. is listed as CH. DISCOV. & NON-CLIN DEV OFF at Olema Pharmaceuticals, Inc. Inside the rolling window, Myles David C. reported no open-market purchases and 4 open-market sales totaling $4.7M in OLMA. The largest disclosed transaction in the window is a sale of 51,000 OLMA shares on Dec 19, 2025, worth $1.6M.
Companies traded
Other insiders at OLMA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Myles David C. made?
Myles David C. has filed 2 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Myles David C. trade?
Myles David C. has filed SEC Form 4 disclosures for 1 company, including OLMA.
When was Myles David C.'s most recent SEC Form 4 filing?
Myles David C.'s most recent SEC Form 4 filing on Tracefour is dated Jan 14, 2026.
What is Myles David C.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Myles David C. is listed as CH. DISCOV. & NON-CLIN DEV OFF.
What is Myles David C.'s total buy and sell value in the current window?
Inside the rolling retention window, Myles David C. bought $0 and sold $4.7M based on SEC Form 4 filings.
What was Myles David C.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 51,000 OLMA shares on 2025-12-19, worth $1.6M, per SEC Form 4 filings.